Developer docs
API playgroundTry for free, no card

Search company profiles

cbdMD

Full company profile

uuid0006g2e

Namestring
cbdMD
Legal namestring
cbdMD, Inc.
Websiteurl
cbdmd.com
Company typeenum
Public
Founded yearint
2015
Descriptiontext

cbdMD, Inc. (AMEX: YCBD) is a Charlotte, North Carolina-based, publicly traded consumer wellness company founded in 2015 that manufactures and sells hemp-derived cannabinoid products under the cbdMD, Bluebird Botanicals, and Herbal Oasis brands. Its core product portfolio spans broad-spectrum and full-spectrum CBD gummies, softgels, oil tinctures, topicals, pet products, and a Delta 9 THC line including nano-emulsified gummies, micro mints, drink mixers, and the Herbal Oasis THC-infused social seltzer. Technical differentiators include nano-emulsion technology for bioavailability and a proprietary scientific platform comprising published OECD-standard preclinical toxicology data, human randomized controlled trial evidence, and GRAS regulatory status that the company positions as unmatched within the hemp-derived CBD category.

The business operates a hybrid go-to-market model. The primary engine is direct-to-consumer e-commerce at cbdMD.com with a Subscribe & Save subscription program offering 25–35% discounts and free priority shipping, complemented by a global wholesale/bulk B2B program for retailers and resellers. Regional distribution partnerships — notably Morales Beverage Group for Herbal Oasis in Louisiana and the Gulf South — extend the beverage line. In April 2026 the company launched a clinical healthcare channel, leveraging CMS guidance activating the Substance Access Beneficiary Engagement Incentive (BEI) to position cbdMD as the first federally enabled hemp-derived CBD supplier in the Medicare channel serving physicians, ACO REACH participants, and Enhancing Oncology Model practices.

Revenue mechanics span one-time purchases, recurring subscriptions, wholesale bulk transactions, and emerging enterprise clinical sales. Recent corporate actions include the January 2026 acquisition of Gaia Botanicals' assets (including the Bluebird Botanicals brand and online marketplace) via an all-equity transaction, a $2.25M preferred financing from C/M Capital Master Fund, a Charlotte lease restructuring that reduces gross rent by approximately $450K annually, and a shareholder-authorized reverse stock split. The company employs 101–250 people, reports on the AMEX exchange, and is pursuing a turnaround strategy following a sharp 81.19% 52-week decline in equity value.

Short descriptiontext

cbdMD is a publicly traded Charlotte, NC-based consumer wellness company that sells hemp-derived CBD and Delta 9 THC products — including gummies, softgels, tinctures, topicals, beverages, and pet products — through DTC e-commerce, wholesale, regional distributors, and a new Medicare clinical channel.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCharlotte, United States
HQ citystring
Charlotte
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
CBD wellness products, hemp-derived CBD, THC beverages, CBD gummies, broad spectrum CBD
Industry7 codes
PRIMARYCRANAHAA
CBD/Hemp Specialty Stores (Tinctures, Oils, Edibles)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Specialty Retail (CBD/Hemp & Accessories)
SECONDARYCRANAHAC
CBD/Hemp Wellness & Supplements Retail
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Specialty Retail (CBD/Hemp & Accessories)
SECONDARYCRANAHAB
CBD/Hemp Topicals & Beauty Retail
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Specialty Retail (CBD/Hemp & Accessories)
SECONDARYCRANAHAD
Hemp-Derived Delta-8/Delta-9/THC-A Specialty Retail (Where Legal)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Specialty Retail (CBD/Hemp & Accessories)
SECONDARYCRANAHAF
CBD/Hemp Pet Products Retail
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Specialty Retail (CBD/Hemp & Accessories)
SECONDARYCRAFACAC
Health & Wellness (Vitamins, Supplements, OTC) DTC
Consumer Products & Retail/E-commerce & Marketplaces/Direct-to-Consumer (DTC) Brand E-commerce
SECONDARYCRAOAIAG
Hemp & CBD Product Wholesale Distribution
Consumer Products & Retail/Wholesale, Distribution & Category Management/Alcohol, Tobacco & Cannabis Wholesale Distribution
NAICS code3 codes
  • Food (Health) Supplement Retailers456191
  • Medicinal and Botanical Manufacturing325411
  • Health and Personal Care Retailers456
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
CBD and Hemp-Derived Wellness Consumer Products
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Direct-to-Consumer E-commerce
TypeSubscription Recurring
Description

Online sales of CBD and THC products through cbdMD.com website, including one-time purchases and Subscribe & Save recurring revenue model with 25-35% subscriber discounts

cbdmd.com
2Wholesale and Distribution
TypeTransaction Fee
Description

Bulk wholesale sales to retailers and distribution partners, including expansion of Herbal Oasis THC beverages through regional distributors

prnewswire.com
3Clinical Healthcare Channel
TypeTransaction Fee
Description

Sales to physicians, health systems, and value-based care organizations participating in Medicare programs under CMS BEI pathway

stocktitan.net
4Acquisition Integration - Bluebird Botanicals
TypeOne Time License
Description

Revenue streams expanded through Bluebird Botanicals brand acquisition including online CBD marketplace

investing.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Marketing or Sales, Personnel, Supply Chain, Technology or R&D
Pricing details4 tiers
1One-Time Purchase - Full retail price
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Products range $14.99 (Delta 9 THC Micro Mints 5ct) to $114.99 (Broad Spectrum CBD Gummies 6000MG). Delta 9 THC products range $49.99-$64.99.

cbdmd.com
2Subscribe & Save - 25% off base price
ModelSubscriptionBilling cadenceMonthly
Notes

25% off all orders with FREE priority shipping. Reschedule, hold, or cancel anytime. 60-day money-back guarantee. Prepaid plans for 3, 6, or 12 shipments offer up to 35% savings.

cbdmd.com
3Wholesale/Bulk Program
ModelTransaction based/ take rateBilling cadenceMulti-year contract
Notes

Bulk wholesale CBD pricing available, targeting retailers and resellers

cbdmd.com
4Special Programs
ModelOtherBilling cadenceMonthly
Notes

Military & Disability discount programs available. Affiliate program with commission-based pricing.

cbdmd.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Bluebird Botanicals
Description

Acquired CBD brand including online CBD marketplace, trademarks, and related inventory.

investing.com
+1 more record
Core offering1 text field

cbdMD develops, manufactures/brands, and sells a portfolio of hemp-derived CBD and ancillary wellness products—including gummies, tinctures, softgels, topicals, pet products, Delta-9 THC products, and THC beverages—primarily through direct-to-consumer e-commerce with subscription, plus wholesale distribution, distributor partnerships, and a clinical healthcare channel serving Medicare-eligible patients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 12% sequential revenue growth in Q1 FY2026 following Bluebird Botanicals acquisition
+2 more records
Product overview1 text field

cbdMD is a leading CBD wellness brand offering a diversified portfolio of hemp-derived products across multiple delivery formats. The core product line includes broad spectrum and full spectrum CBD gummies, softgels/capsules, oil tinctures, and topicals with product categories for sleep, calm, focus, recovery, and relaxation benefits. The Delta 9 THC product line (YCBD) features nano-emulsified and micro-dose gummies, drink mixers, and the Herbal Oasis THC-infused social seltzer beverage brand. The company serves consumers seeking wellness products, retail partners through wholesale channels, and has recently launched a Clinical Healthcare Channel enabling Medicare-covered hemp-derived CBD access for physicians and health systems. The Bluebird Botanicals brand, acquired from Gaia Botanicals assets, expands the company's scientific platform and online marketplace. Key brand differentiators include GMP certification, independent lab testing, and published OECD-standard preclinical toxicology data supporting regulatory positioning.

Product and service11 records
1cbdMD Gummies (Sleep, Calm, Focus, Immune, and Recovery formulations)
CategoryIngestible CBD Gummies
Description

Flavored broad-spectrum CBD gummy SKUs targeted at common daily wellness needs (sleep, calm/stress, focus, immune support, post-workout recovery); for adults buying direct online, via retail, or through the company's subscription program.

2cbdMD Tinctures/Oils
CategoryCBD Tinctures
Description

Sublingual broad-spectrum and full-spectrum CBD tinctures sold in multiple strengths under the cbdMD brand; for individual consumers and wholesale partners seeking versatile, label-tested CBD formats.

3cbdMD Softgels
CategoryCBD Softgels
Description

Pre-measured broad-spectrum or full-spectrum CBD softgels for consistent daily dosing in a familiar supplement form; target individual consumers and the subscription channel.

4cbdMD Topicals (creams, balms, roll-ons)
CategoryCBD Topicals
Description

Topical CBD creams, balms, and roll-ons positioned for targeted application (muscle recovery, joint comfort, skin); sold through DTC and retail partners to adult consumers seeking non-ingestible options.

5cbdMD Pet CBD Products
CategoryPet CBD
Description

CBD oils/tinctures and treats formulated for pets; sold through the cbdMD DTC site for pet owners and through select retail accounts.

6Delta-9 THC Products
CategoryHemp-derived Delta-9 THC
Description

Adult-use Delta-9 THC ingestibles, topicals, and SKUs compliant with federal hemp-derived THC thresholds; sold to individual consumers through the company's online channels and partner retailers where state regulation permits.

7Herbal Oasis THC Beverages
CategoryTHC-Infused Beverages
Description

Herbal Oasis brand of hemp-derived THC-infused beverages; for adult consumers seeking a low-calorie, format-differentiated alternative to gummies and tinctures.

8Bluebird Botanicals brand of CBD wellness products
CategoryCBD Wellness Products (alternative brand)
Description

Bluebird Botanicals brand product line (gummies, tinctures, softgels, and topicals) positioned at a different price point and audience from cbdMD; sold through DTC and wholesale within the company's brand portfolio.

9Subscribe & Save Subscription Program
CategorySubscription Service
Description

Recurring home delivery subscription of cbdMD products through the direct-to-consumer site, offering discounted pricing and predictable replenishment for repeat users.

10Wholesale and Distributor Program
CategoryWholesale Distribution
Description

Wholesale and distributor partnership program enabling retail accounts, pharmacies, and natural-product stores to purchase cbdMD, Bluebird Botanicals, and Herbal Oasis SKUs for on-shelf sale in U.S. markets where legal.

11Clinical Healthcare Channel Product Line (GRAS CBD Isolate)
CategoryHealthcare/Clinical CBD
Description

CBD isolate SKU registered as a self-affirmed Generally Recognized As Safe (GRAS) ingredient with supporting OECD-compliant toxicology data and an FDA submission; routed via the company's clinical healthcare channel to eligible Medicare populations and partner healthcare providers.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierMinorTypeOthersAnnounced on2026-03-30
Description

Ratified as company's auditor at 2026 Annual Meeting of Shareholders.

2Morales Beverage Group
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-02-02
Description

Regional distribution partnership for Herbal Oasis THC-infused social seltzer brand. cbdMD's functional beverage brand expands into Louisiana market through Morales Beverage Group, targeting consumers seeking modern alcohol alternatives. Collaboration includes shipping starting late February 2026 following early success in Texas market, extending regional footprint across Gulf South.

prnewswire.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-12
Description

Asset Purchase Agreement to acquire substantially all assets of Gaia Botanicals including Bluebird Botanicals brand, online CBD marketplace, related trademarks, and inventory. Transaction valued at 425,000 restricted common shares at closing plus up to 525,000 earnout shares. Includes assumption of certain liabilities. All-equity transaction expanding revenue streams, IP, and regulatory assets.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Vertically integrated CBD brand selling tinctures, capsules, topicals, and pet products DTC with strong value positioning and assistance programs. Comparable to cbdMD on hemp-derived product breadth and direct-to-consumer focus.

TypeBroad incumbent
Description

Cannabis consumer products company with hemp-derived CBD offerings under brands like Spinach and Lord Jones. Comparable to cbdMD as a broader incumbent operating in adjacent consumer cannabinoid categories.

TypeBroad incumbent
Description

Global cannabis leader with CBD wellness products and beverage initiatives. Comparable to cbdMD as a broader incumbent with overlapping CBD consumer products and strategic interest in THC-infused beverages.

TypeDirect peer
Description

Publicly traded CBD wellness brand selling tinctures, gummies, capsules, and topicals through DTC e-commerce and wholesale channels. Directly comparable to cbdMD on product mix, distribution model, and target consumer segments.

TypeDirect peer
Description

CBD wellness brand founded by pharmacists, selling gummies, oils, topicals, and pet products through DTC and retail/wholesale. Comparable to cbdMD on product mix, regulatory positioning, and pharmacist-led credibility.

TypeBroad incumbent
Description

Multi-state cannabis operator with a Select CBD/hemp product line sold through dispensaries and retail. Comparable to cbdMD as a broader incumbent in hemp-derived cannabinoids with deep distribution infrastructure.

TypeDirect peer
Description

Publicly traded company focused on hemp-derived CBD consumer products (PlusCBD Oil brand) across retail and DTC. Similar science-led positioning with published clinical research on hemp extracts and comparable regulatory strategy.

TypeDirect peer
Description

DTC CBD brand offering tinctures, gummies, topicals, and pet products through e-commerce and wholesale. Closely comparable to cbdMD on product portfolio, pricing, and target wellness consumer.

TypeBroad incumbent
Description

Established herbal supplement brand expanding into hemp-derived CBD products across broad retail distribution. Comparable to cbdMD as a broader incumbent moving into the same hemp-CBD category with deeper retail relationships.

10Tilray Brands
TypeBroad incumbent
Description

Large Canadian cannabis company with broad hemp and CBD product portfolio across North America. Comparable to cbdMD as a broader incumbent operating in the same hemp-derived CBD retail space with significantly larger scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

cbdMD

CBD and Hemp-Derived Wellness Consumer Productscbdmd.com

cbdMD is a publicly traded Charlotte, NC-based consumer wellness company that sells hemp-derived CBD and Delta 9 THC products — including gummies, softgels, tinctures, topicals, beverages, and pet products — through DTC e-commerce, wholesale, regional distributors, and a new Medicare clinical channel.

What cbdMD does

cbdMD, Inc. (AMEX: YCBD) is a Charlotte, North Carolina-based, publicly traded consumer wellness company founded in 2015 that manufactures and sells hemp-derived cannabinoid products under the cbdMD, Bluebird Botanicals, and Herbal Oasis brands. Its core product portfolio spans broad-spectrum and full-spectrum CBD gummies, softgels, oil tinctures, topicals, pet products, and a Delta 9 THC line including nano-emulsified gummies, micro mints, drink mixers, and the Herbal Oasis THC-infused social seltzer. Technical differentiators include nano-emulsion technology for bioavailability and a proprietary scientific platform comprising published OECD-standard preclinical toxicology data, human randomized controlled trial evidence, and GRAS regulatory status that the company positions as unmatched within the hemp-derived CBD category.

The business operates a hybrid go-to-market model. The primary engine is direct-to-consumer e-commerce at cbdMD.com with a Subscribe & Save subscription program offering 25–35% discounts and free priority shipping, complemented by a global wholesale/bulk B2B program for retailers and resellers. Regional distribution partnerships — notably Morales Beverage Group for Herbal Oasis in Louisiana and the Gulf South — extend the beverage line. In April 2026 the company launched a clinical healthcare channel, leveraging CMS guidance activating the Substance Access Beneficiary Engagement Incentive (BEI) to position cbdMD as the first federally enabled hemp-derived CBD supplier in the Medicare channel serving physicians, ACO REACH participants, and Enhancing Oncology Model practices.

Revenue mechanics span one-time purchases, recurring subscriptions, wholesale bulk transactions, and emerging enterprise clinical sales. Recent corporate actions include the January 2026 acquisition of Gaia Botanicals' assets (including the Bluebird Botanicals brand and online marketplace) via an all-equity transaction, a $2.25M preferred financing from C/M Capital Master Fund, a Charlotte lease restructuring that reduces gross rent by approximately $450K annually, and a shareholder-authorized reverse stock split. The company employs 101–250 people, reports on the AMEX exchange, and is pursuing a turnaround strategy following a sharp 81.19% 52-week decline in equity value.

cbdMD firmographics

Firmographics
Name
cbdMD
Legal name
cbdMD, Inc.
Website
https://cbdmd.com
Company type
Public
Founded year
2015
Operating status
Operating
Headcount range
51–100 employees
Short description
cbdMD is a publicly traded Charlotte, NC-based consumer wellness company that sells hemp-derived CBD and Delta 9 THC products — including gummies, softgels, tinctures, topicals, beverages, and pet products — through DTC e-commerce, wholesale, regional distributors, and a new Medicare clinical channel.
Ownership category
akta.pro rank

cbdMD industry classification

Industry
Product category
CBD and Hemp-Derived Wellness Consumer Products
NAICS
Food (Health) Supplement Retailers (456191), Medicinal and Botanical Manufacturing (325411), Health and Personal Care Retailers (456)
SIC
Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYCRANAHAA
CBD/Hemp Specialty Stores (Tinctures, Oils, Edibles)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Specialty Retail (CBD/Hemp & Accessories)
SECONDARYCRANAHAC
CBD/Hemp Wellness & Supplements Retail
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Specialty Retail (CBD/Hemp & Accessories)
SECONDARYCRANAHAB
CBD/Hemp Topicals & Beauty Retail
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Specialty Retail (CBD/Hemp & Accessories)
SECONDARYCRANAHAD
Hemp-Derived Delta-8/Delta-9/THC-A Specialty Retail (Where Legal)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Specialty Retail (CBD/Hemp & Accessories)
SECONDARYCRANAHAF
CBD/Hemp Pet Products Retail
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Specialty Retail (CBD/Hemp & Accessories)
SECONDARYCRAFACAC
Health & Wellness (Vitamins, Supplements, OTC) DTC
Consumer Products & Retail/E-commerce & Marketplaces/Direct-to-Consumer (DTC) Brand E-commerce
SECONDARYCRAOAIAG
Hemp & CBD Product Wholesale Distribution
Consumer Products & Retail/Wholesale, Distribution & Category Management/Alcohol, Tobacco & Cannabis Wholesale Distribution

Keywords

  • CBD wellness products
  • Hemp-derived CBD
  • THC beverages
  • CBD gummies
  • Broad spectrum CBD

Where cbdMD is headquartered

Location

Headquarters

HQ city
Charlotte
HQ country
United States
HQ region
North America

Offices1 record

Markets served

cbdMD business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Operations, Marketing or Sales, Personnel, Supply Chain, Technology or R&D

Revenue model

  1. Direct-to-Consumer E-commerce: Online sales of CBD and THC products through cbdMD.com website, including one-time purchases and Subscribe & Save recurring revenue model with 25-35% subscriber discounts
  2. Wholesale and Distribution: Bulk wholesale sales to retailers and distribution partners, including expansion of Herbal Oasis THC beverages through regional distributors
  3. Clinical Healthcare Channel: Sales to physicians, health systems, and value-based care organizations participating in Medicare programs under CMS BEI pathway
  4. Acquisition Integration - Bluebird Botanicals: Revenue streams expanded through Bluebird Botanicals brand acquisition including online CBD marketplace

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goOne-Time Purchase - Full retail price
SubscriptionMonthlySubscribe & Save - 25% off base price
Transaction based/ take rateMulti-year contractWholesale/Bulk Program
OtherMonthlySpecial Programs

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

cbdMD product offering

Product offering

Core offering

cbdMD develops, manufactures/brands, and sells a portfolio of hemp-derived CBD and ancillary wellness products—including gummies, tinctures, softgels, topicals, pet products, Delta-9 THC products, and THC beverages—primarily through direct-to-consumer e-commerce with subscription, plus wholesale distribution, distributor partnerships, and a clinical healthcare channel serving Medicare-eligible patients.

Product overview

cbdMD is a leading CBD wellness brand offering a diversified portfolio of hemp-derived products across multiple delivery formats. The core product line includes broad spectrum and full spectrum CBD gummies, softgels/capsules, oil tinctures, and topicals with product categories for sleep, calm, focus, recovery, and relaxation benefits. The Delta 9 THC product line (YCBD) features nano-emulsified and micro-dose gummies, drink mixers, and the Herbal Oasis THC-infused social seltzer beverage brand. The company serves consumers seeking wellness products, retail partners through wholesale channels, and has recently launched a Clinical Healthcare Channel enabling Medicare-covered hemp-derived CBD access for physicians and health systems. The Bluebird Botanicals brand, acquired from Gaia Botanicals assets, expands the company's scientific platform and online marketplace. Key brand differentiators include GMP certification, independent lab testing, and published OECD-standard preclinical toxicology data supporting regulatory positioning.

Differentiator

Problem solved

Functional benefit

Brands

  • Bluebird Botanicals: Acquired CBD brand including online CBD marketplace, trademarks, and related inventory.
  • Herbal Oasis

Products and services

  • cbdMD Gummies (Sleep, Calm, Focus, Immune, and Recovery formulations) Flavored broad-spectrum CBD gummy SKUs targeted at common daily wellness needs (sleep, calm/stress, focus, immune support, post-workout recovery); for adults buying direct online, via retail, or through the company's subscription program.
  • cbdMD Tinctures/Oils Sublingual broad-spectrum and full-spectrum CBD tinctures sold in multiple strengths under the cbdMD brand; for individual consumers and wholesale partners seeking versatile, label-tested CBD formats.
  • cbdMD Softgels Pre-measured broad-spectrum or full-spectrum CBD softgels for consistent daily dosing in a familiar supplement form; target individual consumers and the subscription channel.
  • cbdMD Topicals (creams, balms, roll-ons) Topical CBD creams, balms, and roll-ons positioned for targeted application (muscle recovery, joint comfort, skin); sold through DTC and retail partners to adult consumers seeking non-ingestible options.
  • cbdMD Pet CBD Products CBD oils/tinctures and treats formulated for pets; sold through the cbdMD DTC site for pet owners and through select retail accounts.
  • Delta-9 THC Products Adult-use Delta-9 THC ingestibles, topicals, and SKUs compliant with federal hemp-derived THC thresholds; sold to individual consumers through the company's online channels and partner retailers where state regulation permits.
  • Herbal Oasis THC Beverages Herbal Oasis brand of hemp-derived THC-infused beverages; for adult consumers seeking a low-calorie, format-differentiated alternative to gummies and tinctures.
  • Bluebird Botanicals brand of CBD wellness products Bluebird Botanicals brand product line (gummies, tinctures, softgels, and topicals) positioned at a different price point and audience from cbdMD; sold through DTC and wholesale within the company's brand portfolio.
  • Subscribe & Save Subscription Program Recurring home delivery subscription of cbdMD products through the direct-to-consumer site, offering discounted pricing and predictable replenishment for repeat users.
  • Wholesale and Distributor Program Wholesale and distributor partnership program enabling retail accounts, pharmacies, and natural-product stores to purchase cbdMD, Bluebird Botanicals, and Herbal Oasis SKUs for on-shelf sale in U.S. markets where legal.
  • Clinical Healthcare Channel Product Line (GRAS CBD Isolate) CBD isolate SKU registered as a self-affirmed Generally Recognized As Safe (GRAS) ingredient with supporting OECD-compliant toxicology data and an FDA submission; routed via the company's clinical healthcare channel to eligible Medicare populations and partner healthcare providers.

Quantifiable outcome

  • 12% sequential revenue growth in Q1 FY2026 following Bluebird Botanicals acquisition
  • +2 more outcomes

Companies that use cbdMD

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

cbdMD technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

cbdMD partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered minor and core.

  • Cherry Bekaert LLPminorOthers · 30 March 2026Ratified as company's auditor at 2026 Annual Meeting of Shareholders.
  • Morales Beverage GroupcoreChannel Partner/ Reseller/ Distributor · 2 February 2026Regional distribution partnership for Herbal Oasis THC-infused social seltzer brand. cbdMD's functional beverage brand expands into Louisiana market through Morales Beverage Group, targeting consumers seeking modern alcohol alternatives. Collaboration includes shipping starting late February 2026 following early success in Texas market, extending regional footprint across Gulf South.
  • Gaia Botanicals, LLCcoreStrategic or Co-development Partner · 12 January 2026Asset Purchase Agreement to acquire substantially all assets of Gaia Botanicals including Bluebird Botanicals brand, online CBD marketplace, related trademarks, and inventory. Transaction valued at 425,000 restricted common shares at closing plus up to 525,000 earnout shares. Includes assumption of certain liabilities. All-equity transaction expanding revenue streams, IP, and regulatory assets.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

cbdMD competitors and assessment

Company assessment

Direct peers

  • Lazarus Naturals: Vertically integrated CBD brand selling tinctures, capsules, topicals, and pet products DTC with strong value positioning and assistance programs. Comparable to cbdMD on hemp-derived product breadth and direct-to-consumer focus.
  • Charlotte's Web Holdings: Publicly traded CBD wellness brand selling tinctures, gummies, capsules, and topicals through DTC e-commerce and wholesale channels. Directly comparable to cbdMD on product mix, distribution model, and target consumer segments.
  • Green Roads: CBD wellness brand founded by pharmacists, selling gummies, oils, topicals, and pet products through DTC and retail/wholesale. Comparable to cbdMD on product mix, regulatory positioning, and pharmacist-led credibility.
  • CV Sciences (PlusCBD Oil): Publicly traded company focused on hemp-derived CBD consumer products (PlusCBD Oil brand) across retail and DTC. Similar science-led positioning with published clinical research on hemp extracts and comparable regulatory strategy.
  • Medterra CBD: DTC CBD brand offering tinctures, gummies, topicals, and pet products through e-commerce and wholesale. Closely comparable to cbdMD on product portfolio, pricing, and target wellness consumer.

Broad incumbents

  • Cronos Group: Cannabis consumer products company with hemp-derived CBD offerings under brands like Spinach and Lord Jones. Comparable to cbdMD as a broader incumbent operating in adjacent consumer cannabinoid categories.
  • Canopy Growth: Global cannabis leader with CBD wellness products and beverage initiatives. Comparable to cbdMD as a broader incumbent with overlapping CBD consumer products and strategic interest in THC-infused beverages.
  • Curaleaf Holdings: Multi-state cannabis operator with a Select CBD/hemp product line sold through dispensaries and retail. Comparable to cbdMD as a broader incumbent in hemp-derived cannabinoids with deep distribution infrastructure.
  • Irwin Naturals: Established herbal supplement brand expanding into hemp-derived CBD products across broad retail distribution. Comparable to cbdMD as a broader incumbent moving into the same hemp-CBD category with deeper retail relationships.
  • Tilray Brands: Large Canadian cannabis company with broad hemp and CBD product portfolio across North America. Comparable to cbdMD as a broader incumbent operating in the same hemp-derived CBD retail space with significantly larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

cbdMD social profiles

Digital presence

cbdMD compliance and trust

Trust signal

Compliance3 records

cbdMD financial estimates

Financial estimate

Revenue estimate

Valuation estimate

cbdMD leadership team

Management profile

Number of profiles

Profiles1 record

cbdMD subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

cbdMD funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

cbdMD M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about cbdMD

What does cbdMD do?

cbdMD develops, manufactures/brands, and sells a portfolio of hemp-derived CBD and ancillary wellness products—including gummies, tinctures, softgels, topicals, pet products, Delta-9 THC products, and THC beverages—primarily through direct-to-consumer e-commerce with subscription, plus wholesale distribution, distributor partnerships, and a clinical healthcare channel serving Medicare-eligible patients.

Is cbdMD a public or private company?

cbdMD is a public company. It is classified as public and is currently operating.

When was cbdMD founded?

cbdMD was founded in 2015. It employs 51 to 100 people.

Where is cbdMD based?

cbdMD is headquartered in Charlotte, United States, in the North America region.

How does cbdMD make money?

Four revenue lines are on record. Direct-to-Consumer E-commerce is the primary driver. The others are wholesale and Distribution, clinical Healthcare Channel and acquisition Integration - Bluebird Botanicals.

Who are cbdMD's main competitors?

Direct peers on record are Lazarus Naturals, Charlotte's Web Holdings, Green Roads, CV Sciences (PlusCBD Oil) and Medterra CBD. Broad incumbents are Cronos Group, Canopy Growth, Curaleaf Holdings, Irwin Naturals and Tilray Brands.

Does cbdMD have an API?

No public API is recorded for cbdMD.

What industry is cbdMD in?

cbdMD's product category is CBD and Hemp-Derived Wellness Consumer Products. Its primary akta.pro industry code is CRANAHAA, CBD/Hemp Specialty Stores (Tinctures, Oils, Edibles), with a secondary code of CRANAHAC, CBD/Hemp Wellness & Supplements Retail. Its NAICS code is 456191 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswirecbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity WellnesscbdMD entered a definitive agreement to acquire Twinlab's operating assets and brands, including Twinlab, Reserveage, Metabolife, and Alvita Tea, via an assignment for the benefit of creditors. The deal is expected to raise combined revenue to about $30 million, a 40% increase over cbdMD's standalone revenue for the trailing twelve months. The acquisition aims to reduce cbdMD's revenue concentration in the hemp category.Third NewscbdMD Sees Significant Revenue Growth of 20% in Q3 2026, Reflecting Strong Market PositioncbdMD reported a 20% year-over-year revenue increase to $5.6 million for the third quarter of fiscal 2026, driven by strong wholesale performance and the integration of Bluebird Botanicals. The company implemented cost-saving measures expected to save $150,000 monthly while navigating pending federal regulations that have been temporarily extended.Stock TitancbdMD Q3 Earnings: Revenue Rises 20% to $5.6McbdMD reported a 20% year-over-year increase in third-quarter fiscal 2026 revenue to $5.6 million, driven by wholesale sales growth and the first full quarter of contribution from its acquired brand Bluebird Botanicals. The company also expanded distribution for its Oasis beverage brand and is implementing cost-reduction initiatives to improve profitability amid pending federal hemp regulations.FmiblogBroad Spectrum CBD Gummies Market to Reach USD 982.4 Million by 2036 as THC-Free Wellness Demand and Direct-to-Consumer Education Accelerate GrowthFuture Market Insights projects the global broad spectrum CBD gummies market to grow from USD 486.2 million in 2025 to USD 982.4 million by 2036, driven by demand for THC-free wellness products and direct-to-consumer sales. Key players such as cbdMD Inc., Charlotte’s Web Holdings Inc., and Medterra CBD LLC are competing on product transparency, testing, and compliant labeling amid regulatory scrutiny. The United States is identified as the fastest-growing major market with a 7.8% CAGR, followed by Canada and the United Kingdom.PR NewswirecbdMD's Oasis Brand Partners with Mexcor to Launch Into South CarolinacbdMD announced its Oasis hemp-derived beverage line, including the zero-proof Mixer, is now available in South Carolina through Mexcor Beverage Group. The products are stocked at liquor retailers statewide, including Frugal MacDoogal. The rollout aims to place the brand alongside traditional spirits to reach a broader audience.PR NewswirecbdMD Sets a New Safety Standard for Broad Spectrum CBD With Self-Affirmed GRAS DeterminationcbdMD announced a self-affirmed GRAS determination supporting safe consumption of up to 200 mg daily of its broad-spectrum CBD in healthy adults. The determination follows years of peer-reviewed safety research across species, including human and canine studies. The company cites this as a milestone for evidence-based wellness.PR NewswireOasis Launches Hemp-Derived MixercbdMD launched Oasis Mixer, a quadruple-filtered, zero-proof THC spirit with 10mg THC per serving and 170mg per bottle. The product is available in Citrus and Unflavored, with initial demand exceeding supply. It will be distributed in Tennessee, Florida, Texas, South Carolina, and select North Carolina markets.PR NewswirecbdMD, Inc. to Host Conference Call to Discuss March 31, 2026, Second Quarter ResultscbdMD, Inc. announced it will host a conference call on May 14, 2026, at 4:20 p.m. Eastern Time to discuss its second quarter financial results for the period ending March 31, 2026. The announcement includes dial-in details and a webcast link for the call. No actual financial results, business developments, or performance data are included in this advance notice.Investing.comcbdMD shareholders approve equity plan, reverse stock split and director slate By Investing.comShareholders of cbdMD approved all proposals at the company's 2026 Annual Meeting on March 30, including a 2025 Equity Compensation Plan reserving 891,316 shares with an annual 2% evergreen provision, director elections, and ratification of Cherry Bekaert LLP as auditor. The shareholders also authorized a reverse stock split at a ratio between 1-for-2 and 1-for-10 prior to the one-year anniversary, and approved share issuances related to convertible preferred stock and an equity line of credit with C/M Capital Master Fund potentially exceeding 20% of outstanding shares. Additionally, cbdMD recently completed its acquisition of Bluebird Botanicals through an all-equity transaction and entered into an Asset Purchase Agreement to acquire Gaia Botanicals' assets including the Bluebird Botanicals brand and online CBD marketplace.Stock TitancbdMD Launches Clinical Channel for Medicare CBD PathwaycbdMD announced the launch of its clinical healthcare channel on April 1, 2026, positioning the company to support physicians, health systems, and value-based care organizations following CMS guidance activating the first federal pathway for hemp-derived cannabinoid products in Medicare. The CMS Substance Access Beneficiary Engagement Incentive (BEI), effective the same date, allows participating accountable care organizations and oncology practices in models including ACO REACH and the Enhancing Oncology Model to furnish eligible hemp-derived CBD products to Medicare patients under physician supervision. The company claims its published preclinical toxicology data and human randomized controlled trial data represent an unmatched regulatory platform in the hemp-derived CBD category.